bioRxivCell BiologyPreprint
Small GTPases RhoA and RhoC coordinately regulate cardiomyocyte size in the mouse heart
Vikram PrasadiD, Naga Swathi Sree KavuriiD, Max ToubiniD, J. Matthew Kofron, Yi ZhengiD, Jop H. van BerloiD, Jeffery D. MolkentiniD, Davy VanhoutteiD
Abstract
Rho family GTPases regulate cardiomyocyte growth and cytoskeletal organization, yet the overlapping and individual function of the two primary isoforms RhoA and RhoC, remain largely unknown in the heart. Here, we examined cardiac structure and function at baseline and in response to mechanical and neurohumoral stress in mice with cardiomyocyte-specific deletion of Rhoa, global loss of Rhoc, or combined deficiency of both isoforms. Deletion of either Rhoa or Rhoc increased myocardial expression of the other isoform, showing reciprocal compensation. At baseline, Rhoc deficiency produced elongated, narrower cardiomyocytes, whereas additional loss of Rhoa restored cell width but length remained longer. Combined Rhoa/Rhoc deficiency also disrupted intercalated disc protein expression and organization and caused age-dependent cardiac hypertrophy with mild pulmonary congestion despite preserved systolic function. Following pressure overload, loss of either isoform increased hypertrophy and fibrosis compared with control groups, while combining Rhoa/Rhoc deficiency significantly worsened cardiac remodeling and systolic dysfunction. Neurohumoral stimulation with angiotensin II and phenylephrine similarly revealed cooperative control of hypertrophic growth in Rhoa/Rhoc double deleted cardiomyocytes versus either single deletion. These findings identify RhoA and RhoC as partially compensatory effectors of cardiomyocyte growth and ventricular remodeling with stress stimulation, although their individual contributions to hypertrophic growth, structural integrity, and cardiac function depend on both the nature and duration of cardiac stress.
- organism: mouse
- assay: bulk RNA-seq
- research focus: cell type annotation
- research focus: differential expression
- research focus: gene regulatory network inference
- research focus: drug response / drug discovery
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Systems analysis reveals neuregulin-1 control of cardiomyocyte size and shape mediated by distinct PI3K and p38 pathways
Pichayathida Luanpaisanon, Karen A. Ryall, … Jeffrey J. Saucerman·bioRxiv·Oct 1, 2025
- Myocardial Notch-Rbpj deletion does not affect heart development or function
Alejandro Salguero-Jiménez, Joaquím Grego‐Bessa, … José Luís de la Pompa·PLoS ONEPeer-reviewed·Dec 31, 2018
- Cardiac fibroblasts regulate cardiomyocyte hypertrophy through dynamic regulation of type I collagen
Q. Meng, S. L. K. Bowers, … J. D. Molkentin·bioRxiv·May 25, 2022
- Cardiomyocyte hypertrophy co-localizes with accumulation of hyaluronan in cMyBPC+/- mice hearts
Anna Strnadová, Madelene Ericsson, … Urban Hellman·PLoS ONEPeer-reviewed·Sep 9, 2026
- The nuclear receptor RORα preserves cardiomyocyte mitochondrial function by regulating mitophagy through caveolin-3
Ju Youn Beak, Hyun‐Sik Kang, … Brian C. Jensen·bioRxiv·Oct 2, 2020
- Excitation-contraction coupling plasticity is revealed upon RyR2 depletion in adult mouse ventricular myocytes
Erick B. Ríos Pérez, Achal M. Gowda, … Francisco Alvarado·bioRxiv·Oct 14, 2026